TORPENZ™ is a prescription medicine used to treat tumors associated with the genetic condition tuberous sclerosis complex (TSC).
The medication in TORPENZ™, everolimus, belongs to the family of medications known as mTOR inhibitors. mTOR inhibitors are used to help control abnormal cell division that is seen in a number of medical conditions, including TSC.
TORPENZ™ Tablets are a generic version of Afinitor® (everolimus) Tablets. This means that TORPENZ™ Tablets contain the same active ingredient in the same strength and dosage form, and provide the same efficacy, tolerability, and safety as Afinitor®.1
TORPENZ™ can cause serious side effects, including lung or breathing problems, increased risk of infection, and mouth ulcers and sores. To learn more about these and other risks and side effects associated with TORPENZ™, see the Information for TSC patients.
TORPENZ™ is used to treat benign (non-cancerous) tumors in certain people with the generic condition TSC:
Everolimus was approved for use in people with TSC in 2010. This means that the medical community has many years of experience with it and a good understanding of how to use it safely and effectively.
Do not take TORPENZ™ if you have had a severe allergic reaction to everolimus. Talk to your healthcare provider before taking TORPENZ™ if you are allergic to sirolimus or temsirolimus.